Follow
ISR Immune System Regulation Holding AB
Nasdaq First North Sweden (Sweden)
ISR Immune System Regulation Holding AB is a Sweden based company is engaged in research within the area of immunotherapy. It is principally focused on preclinical and clinical research with the objective to develop novel drugs for curative treatments of viral infections. The group is focused on developing ISR048 technology for the novel treatment of viral infected patients with a focus on human immunodeficiency virus (HIV) infection.
Sector:
HEALTH CARE
>
Biotechnology
Sector:
TECHNOLOGY
Media
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Type
Ticker
ISIN
Market
SHARE
ISR
SE0008212195
Nasdaq First North Sweden
Sweden (SE)
Details of share in ISR Immune System Regulation Holding AB with ticker ISR
Status
Active
Order book id
Amount of instruments
24 718 132
Par value
Market cap
Currency
SEK
Segment
First North
Terms
Type
Price
Pre-money valuation
Time
Files
Listing
24 Mar 2017
Direct listing of ISR Immune System Regulation Holding AB on Nasdaq First North Sweden
Market
Nasdaq First North Sweden
Status
Listed
Comments for listing & related information
ISR Immune System Regulation will be listed on First North on March 24, 2017.
Documents
Type
Price
Pre-money valuation
Time
Files
New issue
2.90 SEK
71.7M SEK
15 May - 29 May 2020
Share issue in ISR Immune System Regulation Holding AB
Market
Nasdaq First North Sweden
Subscription period
15 May - 29 May 2020
Subscription price
8.70 SEK
Price per share
2.90 SEK
Target to raise
71 700 000 SEK
Types
Share issue
Pre-money valuation
71 700 000 SEK
Subscription block size
Minimum subscription
Record date
13 May 2020
Offer status
Closed
Listing status
Listed
Issue terms
Existing shareholders will receive one (1) unit right for every one (1) share owned on the record date on May 13, 2020. Three (3) unit rights give the right to subscribe for one (1) unit. One (1) unit consists of three (3) newly issued shares, one (1) subscription option of series TO1 and one (1) subscription option of series TO2.
Comments for offer & related information
The company issues 8 239 377 units. The rights issue is comprised of approximately 1.4 percent of subscription bonds and approximately 98.6 percent of issue guarantees. In total, the Rights Issue is thus covered by subscription commitments and issue guarantees to 100 percent.
The exercise price for subscription of shares with the support of warrants corresponds to 70 percent of the volume-weighted average payment price for the Company's shares on the Nasdaq First North Growth Market during 10 trading days before the exercise period for each series of warrants. However, the subscription price for subscription of shares in series TO1 cannot be lower than SEK 2.90 and no higher than SEK 8.70 and in series TO2 cannot be lower than SEK 2.90.
Type
Ticker
ISIN
Market
OPTION
ISR TO1
SE0014401766
Nasdaq First North Sweden
Sweden (SE)
Details of option in ISR Immune System Regulation Holding AB with ticker ISR TO1
Status
Inactive
Order book id
Amount of instruments
8 239 377
Market cap
Currency
SEK
First trading date
Terms
The exercise price for subscription of shares with the support of warrants corresponds to 70 percent of the volume-weighted average payment price for the Company's shares on the Nasdaq First North Growth Market during 10 trading days before the exercise period for each series of warrants. However, the subscription price for subscription of shares in series TO1 cannot be lower than SEK 2.90 and no higher than SEK 8.70.
Type
Price
Pre-money valuation
Time
Files
Exercise
2.90-8.70 SEK
24 Feb - 10 Mar 2021
Option exercise terms for ISR TO1
Market
Nasdaq First North Sweden
Exercise period(s)
24 Feb - 10 Mar 2021
Exercise price range
2.90-8.70 SEK
Exercise final price
Status
Upcoming
Issue terms
The exercise price for subscription of shares with the support of warrants corresponds to 70 percent of the volume-weighted average payment price for the Company's shares on the Nasdaq First North Growth Market during 10 trading days before the exercise period for each series of warrants. However, the subscription price for subscription of shares in series TO1 cannot be lower than SEK 2.90 and no higher than SEK 8.70.
Type
Ticker
ISIN
Market
OPTION
ISR TO2
SE0014401774
Nasdaq First North Sweden
Sweden (SE)
Details of option in ISR Immune System Regulation Holding AB with ticker ISR TO2
Status
Inactive
Order book id
Amount of instruments
8 239 377
Market cap
Currency
SEK
First trading date
Terms
The exercise price for subscription of shares with the support of warrants corresponds to 70 percent of the volume-weighted average payment price for the Company's shares on the Nasdaq First North Growth Market during 10 trading days before the exercise period for each series of warrants. However, the subscription price for subscription of shares in series TO2 cannot be lower than SEK 2.90.
Type
Price
Pre-money valuation
Time
Files
Exercise
2.90 SEK
09 Nov - 23 Nov 2021
Option exercise terms for ISR TO2
Market
Nasdaq First North Sweden
Exercise period(s)
09 Nov - 23 Nov 2021
Exercise price
2.90 SEK
Status
Upcoming
Issue terms
The exercise price for subscription of shares with the support of warrants corresponds to 70 percent of the volume-weighted average payment price for the Company's shares on the Nasdaq First North Growth Market during 10 trading days before the exercise period for each series of warrants. However, the subscription price for subscription of shares in series TO2 cannot be lower than SEK 2.90.
People
Number of Employees
1 people
Stig Ola Winqvist
CEO
Anders Milton
Chairman of the board
Hans Olof Glise
Board member
George Gustaaf Wolvaardt
Board member
Jan Erik Gunnar Jardelöv
Board member
Anders Milton
Board member
Company Details
Sector
HEALTH CARE, TECHNOLOGY
Website

Address
Rörstrandsgatan 58
Zip code
113 40
City/district
Stockholm
Country
Sweden (SE)
Registration number
559026-7828
LEI code
5493007QQ16K1NL2PW55
First trade date
24 Mar 2017
Company former names
Natalz AB
30 Sep 2015
GOLDCUP 11680 AB
17 Sep 2015
Registration date
31 Aug 2007
Short name
ISR Immune System Regulation

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More

Create Your FREE Account to stay Up To Date